
Nimozen 50mg Infusion
Marketer
Wohltat Lifesciences
Salt Composition
Nimodipine (50mg)
Overview Nimozen 50mg Infusion
Nimodipine 50mg intravenous infusion is a medication employed to manage and mitigate cerebral injury following a subarachnoid hemorrhage (brain bleed). Classified as a calcium channel blocker, it enhances cerebral perfusion and safeguards cognitive function. Administration of Nimodipine 50mg infusion is strictly under medical supervision; dosage is individualized based on the treatment goal and disease severity. Continue the infusion for the prescribed duration. Strictly adhere to your physician's instructions. Frequently reported adverse effects encompass skin rash, cephalalgia, gastrointestinal upset, hypotension, and bradycardia. Report any persistent, worsening, or bothersome side effects to your doctor immediately. Drowsiness may occur; refrain from operating vehicles or machinery until the drug's effects are known. Disclose any pre-existing cardiac conditions prior to commencement of therapy. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Complete disclosure of all concurrent medications, particularly antihypertensives or cardioactive drugs, is essential.
Uses of Nimozen 50mg Infusion
Bleeding into the subarachnoid space
Major Benefits of Nimozen 50mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Nimozen 50mg Infusion:
- Rash
- Headache
- Stomach discomfort
- Nausea
- Decreased blood pressure
- Slow heart rate
How to use Nimozen 50mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Nimozen 50mg Infusion works:
Nimodipine 50mg infusion, a calcium channel antagonist, dilates constricted cerebral blood vessels, improving blood flow. This action mitigates brain injury following intracranial hemorrhage.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Nimozen 50mg infusion and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Nimozen 50mg Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Nimodipine 50mg infusion safely. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Nimozen 50mg Infusion can lead to drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
Nimozen 50mg Infusion appears to pose minimal risk for individuals with impaired renal function. Existing evidence indicates dose modification for Nimozen 50mg Infusion might be unnecessary in such cases. However, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of 50mg Nimozen infusions to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Nimozen 50mg Infusion :
NA
Facts to Know About Nimozen 50mg Infusion
| Label | Value |
|---|---|
| Chemical Classification | Dihydropyridine carboxylic acid analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Dihydropyridine Calcium Channel Blockers |
